Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
ETX-312 in Metabolic Dysfunction Associated Steatohepatitis: ISRCTN65253349 Clinical Landscape Report 2026
16 September 2026
ISRCTN65253349 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Tranexamic Acid in Hemorrhage: NCT07392034 Clinical Landscape Report 2026
16 September 2026
NCT07392034 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CTx-1000 in Amyotrophic Lateral Sclerosis: NCT07401121 Clinical Landscape Report 2026
16 September 2026
NCT07401121 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SRN-001(siRNAgen Therapeutics) in Idiopathic Pulmonary Fibrosis: NCT07407543 Clinical Landscape Report 2026
16 September 2026
NCT07407543 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HN-2302 in Myasthenia Gravis: NCT07413835 Clinical Landscape Report 2026
16 September 2026
NCT07413835 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Nivolumab in Pneumoconiosis: NCT07420439 Clinical Landscape Report 2026
16 September 2026
NCT07420439 clinical landscape for Pneumoconiosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NSC-706744 in Glioblastoma Multiforme: NCT07416188 Clinical Landscape Report 2026
16 September 2026
NCT07416188 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
nL-CHCHD-001 in Amyotrophic Lateral Sclerosis: NCT07423494 Clinical Landscape Report 2026
16 September 2026
NCT07423494 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
B-cell Vaccination(Northwestern University) in Glioblastoma: NCT07422896 Clinical Landscape Report 2026
16 September 2026
NCT07422896 clinical landscape for Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PBGENE-DMD in Muscular Dystrophy, Duchenne: NCT07429240 Clinical Landscape Report 2026
16 September 2026
NCT07429240 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ETX-312 in Metabolic Dysfunction Associated Steatohepatitis: NCT07427680 Clinical Landscape Report 2026
16 September 2026
NCT07427680 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
ACE-2223 in Neurodegenerative Diseases: ACTRN12626000231347 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000231347 clinical landscape for Neurodegenerative Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…